Subject and method: A prospective, cross-sectional study with comparison and follow-up for 6 months on 65 ischemic heart disease patients with refractive angina pectoris according to criteria of ESC 2013 managed at Internal Cardiology Department of the 108 Military Central Hospital from March 2015 to March 2021.